4.8 Letter

Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer

Journal

NEW ENGLAND JOURNAL OF MEDICINE
Volume 383, Issue 26, Pages 2586-2588

Publisher

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMc2031670

Keywords

-

Funding

  1. National Institutes of Health (NIH)-National Cancer Institute Cancer Center Support Grant from the NIH [P30 CA008748]
  2. Jack and Dorothy Byrne Foundation
  3. National Institute of Allergy and Infectious Diseases [HHSN272201400008C]
  4. Open Philanthropy Project [2020-215611 [5384]]
  5. NIH Office of Research Infrastructure Programs [S10OD018522, S10OD026880]
  6. Robin Chemers Neustein Postdoctoral Fellowship Award
  7. [P01 CA23766]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available